Deerfield Management Company, L.P. (Series C) Spring Works Therapeutics, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$36.5 - $52.5 $47.5 Million - $68.3 Million	-1,301,200 Reduced 50.35%	1,283,176 $63.2 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $19 Million - $37.4 Million	1,004,802 Added 63.61%	2,584,376 $94.3 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $5,202 - $7,060	225 Added 0.01%	1,579,574 $36.5 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $13.6 Million - $18.6 Million	546,349 Added 52.89%	1,579,349 $40.7 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $4.69 Million - $6.2 Million	216,006 Added 26.44%	1,033,000 $26.9 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $19.7 Million - $32.4 Million	816,994 New	816,994 $23.3 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $4.59 Million - $15 Million	-249,988 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $9.89 Million - $13.2 Million	-202,012 Reduced 44.69%	249,988 $14.1 Million
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $3.13 Million - $4.45 Million	-58,673 Reduced 11.49%	452,000 $28 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $3 Million - $4.23 Million	-47,901 Reduced 8.58%	510,673 $32.4 Million
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $57.6 Million - $82.8 Million	-884,396 Reduced 61.29%	558,574 $41.1 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $10.1 Million - $16.3 Million	208,708 Added 16.91%	1,442,970 $105 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $10.2 Million - $21.7 Million	446,019 Added 56.58%	1,234,262 $51.8 Million
Q4 2019 Feb 14, 2020	SELL	$17.74 - $39.52 $4.66 Million - $10.4 Million	-262,645 Reduced 24.99%	788,243 $30.3 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $19.8 Million - $29.2 Million	1,050,888 New	1,050,888 $22.8 Million

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

Vanguard Group Inc Valley Forge, PA

6.71M
Shares

$239 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.62M
Shares

$200 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

3.84M
Shares

$137 Million
4.54% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.52M
Shares

$125 Million
0.01% of portfolio
Boxer Capital, LLC San Diego, CA

3.42M
Shares

$122 Million
5.82% of portfolio

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account